Omega-3s show promise for Tough-to-Treat depression

NCT ID NCT05774665

Ongoing Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study looked at whether omega-3 fatty acids can reduce inflammation and improve mood in adults with treatment-resistant depression. Fourteen participants who were already on antidepressants but still depressed were randomly given either omega-3 supplements or a placebo for 12 weeks. The researchers measured anti-inflammatory compounds in the blood and tracked depression symptoms to see if omega-3s could help.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depressive Disorder, Treatment-Resistant Inflammation inflammatory disease major depressive disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATION OVERWEIGHT TREATMENT RESISTANT DEPRESSION

Contacts and locations

Locations

Depression Clinical and Research Program at Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Emory University School of Medicine

Atlanta, Georgia, 30322, United States
University of Utah

Salt Lake City, Utah, 84108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.